5/30 - OPTR FDA decision on fidaxomicin for Clostridium difficile infection
6/23 - PTIE FDA decision on Remoxy in Pain
7/14 - TSPT FDA decision on Intermezzo in sleep disorder
=============================================
================================================
For potentially more up-to-date calendars, you can try these out.
Trout Capital Biotech calendar
http://www.troutcapital.com/conferences-events/calendar.aspx
BioPharmCatalyst
http://www.biopharmcatalyst.com/
http://www.troutcapital.com/conferences-events/calendar.aspx
BioPharmCatalyst
http://www.biopharmcatalyst.com/
1- Do your own due diligence BEFORE purchasing any company.
2- Be aware 510(k) decisions are notorious for not being on-time. 90 days is used, but the FDA has not been sticking to it.
3- If there are errors, let me know. I will do my best to update this.